Compare ANIP & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | ALGT |
|---|---|---|
| Founded | 2001 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1999 | 2006 |
| Metric | ANIP | ALGT |
|---|---|---|
| Price | $78.18 | $75.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 10 |
| Target Price | ★ $110.00 | $97.30 |
| AVG Volume (30 Days) | 315.6K | ★ 534.0K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 419.23 | 81.62 |
| EPS | 1.28 | ★ 2.30 |
| Revenue | $206,547,000.00 | ★ $2,606,579,000.00 |
| Revenue This Year | $21.01 | $9.42 |
| Revenue Next Year | $17.59 | $6.52 |
| P/E Ratio | $61.90 | ★ $34.94 |
| Revenue Growth | 2.47 | ★ 3.74 |
| 52 Week Low | $56.71 | $43.03 |
| 52 Week High | $99.50 | $118.00 |
| Indicator | ANIP | ALGT |
|---|---|---|
| Relative Strength Index (RSI) | 45.10 | 43.58 |
| Support Level | $77.46 | $73.38 |
| Resistance Level | $83.58 | $94.77 |
| Average True Range (ATR) | 3.12 | 3.81 |
| MACD | -0.46 | 0.08 |
| Stochastic Oscillator | 15.12 | 32.74 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.